Structural biologist and researcher, Doug Rosenthal, along with his team from Cleveland, Ohio, have recognized protein synthesis, or biosynthetic capacity, as a key property to regeneration of the cancer cells of colon cancer.
The work of
Rosenthal, gives a new therapeutic approach. The
scientific community and pharmaceutical companies will explore more in depth
this approach.
